Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Research Seed Money Grant

National Ataxia Foundation

The NAF Research Seed Money Grant provides support for new and innovative studies that advance understanding of the cause, pathogenesis, or treatment of hereditary, sporadic, and acquired ataxias. These $50,000, 1-year grants serve as seed funding to assist investigators during the early or pilot phases of research, or as supplemental funding for ongoing innovative projects demonstrating a critical need. It is expected that funded projects will generate preliminary data to support applications for larger grants from other funding sources.

Research Seed Grant Funding Priorities

NAF is committed to supporting research that advances scientific discovery and improves outcomes for all individuals living with ataxia, regardless of disease subtype. During this funding cycle, equal priority will be given to the following research focus areas:

For proposals targeting more common and better-characterized forms of ataxia (e.g., SCA types 1,2,3,6, FA), funded projects are expected to have strong translational potential. These projects should aim to:
- Advance clinical trial readiness,
- Support or accelerate the development of treatments,
- Significantly alter our understanding of disease mechanisms or pathogenesis,
- Or meaningfully impact clinical care and patient outcomes (speech, physical therapy, and other supportive therapies studies encouraged).
For proposals focused on rare, less characterized, unknown or newly identified forms of ataxia, NAF encourages research that builds critical foundational knowledge. These projects may focus on:
- Addressing fundamental mechanistic questions,
- Developing or validating novel disease models, without necessarily demonstrating immediate translational application.

LOI Deadline

August 15, 2025 by 11:59 PM Eastern Time

Application Deadline

December 5, 2025 by 11:59 PM Eastern Time

Application is not available until LOI has been approved.

Funding Information

Funding Period: April 1, 2026 – March 31, 2027
Grant Amount: Up to $50,000
Use of Funds: Funds may be used for direct research expenses only.
- Personnel Costs: No more than 50% of the award may be allocated to personnel expenses.
- Indirect Costs/Cost Sharing: Not allowed.
No-Cost Extensions (NCE): Considered only under extenuating circumstances and subject to NAF approval.

NAF retains the right to unilaterally cancel awards for nonperformance or noncompliance.

Specialties

Clinical Trials

Eligibility Requirements

1. Applicants must have completed their post-doctoral training and have a full-time appointment as a faculty member, clinical fellow, or senior scientist at a research institution.

2. Non-U.S. citizens are eligible to apply for this NAF grant award.

3. Grant applications are accepted from U.S. and international institutions.

4. Individuals are ineligible if they were the lead PI on an awarded NAF grant within the past two fiscal years.

5. Applicants are only eligible to submit one application per year. Applicants should select the grant program that best suits their current position and proposal.

Sponsor Details

Sponsor Institute/Organizations: National Ataxia Foundation

Sponsor Type: Corporate/Non-Profit

Address: 600 Highway 169 South, Suite 1725 Minneapolis, MN 55426

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity